Method for ovarian cancer risk assessment in patients with adnexal neoplasm

Ronalds Mačuks; Simona Doniņa

Method for ovarian cancer risk assessment in patients with adnexal neoplasm

Translated title of the contribution: Olnīcu vēža riska noteikšanas paņēmiens sievietēm ar veidojumu dzemdes piedēkļu rajonā

Ronalds Mačuks (Inventor)
, Simona Doniņa (Inventor)

Rīga Stradiņš University

Research output: Innovations, Intellectual property, Prototypes › Patent

Abstract

Invention relates to oncological examinations in gynaecology. Human epidydimis secretory protein 4 is suggested to be used as an indicator in assessment of cancer risk in patients with adnexal neoformations.

Translated title of the contribution	Olnīcu vēža riska noteikšanas paņēmiens sievietēm ar veidojumu dzemdes piedēkļu rajonā
Original language	Latvian
Patent number	14703
IPC	G01N33/53
Priority date	2/05/13
Filing date	2/05/13
Publication status	Published - 20 Dec 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords*

assessment of ovarian cancer risk

Field of Science*

3.2 Clinical medicine

Access to Document

http://databases.lrpv.gov.lv/databases/lv/patent/details/p-13-55/

Cite this

@misc{e0bcbeea8b9a4801ab42dc4dae162ae7,

title = "Method for ovarian cancer risk assessment in patients with adnexal neoplasm",

abstract = "Invention relates to oncological examinations in gynaecology. Human epidydimis secretory protein 4 is suggested to be used as an indicator in assessment of cancer risk in patients with adnexal neoformations.",

keywords = "assessment of ovarian cancer risk",

author = "Ronalds Ma{\v c}uks and Simona Doniņa",

year = "2013",

month = dec,

day = "20",

language = "Latvian",

publisher = "Patent Office of the Republic of Latvia",

type = "Patent",

note = "14703; G01N33/53",

}

TY - PAT

T1 - Method for ovarian cancer risk assessment in patients with adnexal neoplasm

AU - Mačuks, Ronalds

AU - Doniņa, Simona

PY - 2013/12/20

Y1 - 2013/12/20

N2 - Invention relates to oncological examinations in gynaecology. Human epidydimis secretory protein 4 is suggested to be used as an indicator in assessment of cancer risk in patients with adnexal neoformations.

AB - Invention relates to oncological examinations in gynaecology. Human epidydimis secretory protein 4 is suggested to be used as an indicator in assessment of cancer risk in patients with adnexal neoformations.

KW - assessment of ovarian cancer risk

UR - https://www.lrpv.gov.lv/lv/media/1079/download

M3 - Patent

M1 - 14703

Y2 - 2013/05/02

PB - Patent Office of the Republic of Latvia

ER -

Method for ovarian cancer risk assessment in patients with adnexal neoplasm

Abstract

UN SDGs

Keywords*

Field of Science*

Access to Document

Other files and links

Fingerprint

Cite this